Redwood Investments, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Redwood Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$39.62 - $69.97 $245,366 - $433,324	-6,193 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$58.09 - $82.51 $50,828 - $72,196	875 Added 16.45%	6,193 $411,000
Q3 2021 Oct 19, 2021	SELL	$58.38 - $84.96 $105,726 - $153,862	-1,811 Reduced 25.4%	5,318 $332,000
Q2 2021 Aug 02, 2021	BUY	$62.15 - $90.32 $30,329 - $44,076	488 Added 7.35%	7,129 $590,000
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $22,208 - $32,750	362 Added 5.77%	6,641 $440,000
Q4 2020 Feb 05, 2021	BUY	$43.82 - $85.37 $275,145 - $536,038	6,279 New	6,279 $482,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.76B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.